$COCH News

Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street

Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology

Envoy Medical Secures Multiple Australia And Europe Patents For Implantable Hearing System Innovations And Battery Recharge Safety Technology

Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant

Envoy Medical Q1 EPS $(0.08) Beats $(0.14) Estimate, Sales $39.000K Miss $60.000K Estimate

Envoy Medical Achieves Full Enrollment Of U.S. Pivotal Clinical Study To Evaluate Fully Implanted Cochlear Implant Seeking FDA Nod

TransMedics (TMDX) Q1 Earnings and Revenues Miss Estimates

Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical Announces First Podium Presentations Of Clinical Data From First Stage Of Pivotal Clinical Study Of Investigational Acclaim Cochlear Implant, Fully Implanted Cochlear Implant System

Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant

Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant

Envoy Medical Hits 12-Month Milestone For First Wave Of Cochlear Implant Trial

HC Wainwright & Co. Initiates Coverage On Envoy Medical with Buy Rating, Announces Price Target of $2.5

Envoy Medical Reports Full Year 2025 Financial Results

Envoy Medical Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $75.000K Beat $70.000K Estimate

Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

EXCLUSIVE: Envoy Medical Hits Trial Milestone For Cochlear Implant Designed To Work With Natural Ear

EXCLUSIVE: Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

EXCLUSIVE: Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

Envoy Medical Regains Compliance with Nasdaq Listing Requirement